LRP1 and breast carcinoma: Inspired by the fact that statins can suppress cholesterol synthesis and then induce compensatory expression of LRP1 [118,123,124,125,126], simvastatin-loaded nanoparticles were reported in our previous work to upregulate LRP1 at the BBB and boost LRP1-targeting chemotherapy efficiency against brain metastases from breast cancer [114].